Resistance to Antiviral Drugs of Herpes Simplex Virus Isolated from a Patient Treated with Acyclovir

New England Journal of Medicine

Volumn 306, Issue 6, 1982, Pages 343-346

  Crumpacker, Clyde S ^a   Schnipper, Lowell E ^a   Marlowe, Steven I ^a   Kowalsky, Patricia N ^a   Hershey, Brenda J ^a   Levin, Myron J ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; ACICLOVIR; ANTIVIRUS AGENT; PHOSPHONOACETIC ACID; VIDARABINE;

ANIMAL EXPERIMENT; DRUG RESISTANCE; FIBROBLAST; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HUMAN CELL; IMMUNE DEFICIENCY; IN VITRO STUDY; PREMEDICATION; VIRUS ISOLATION; VIRUS MUTATION;

EID: 0020067694     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198202113060606     Document Type: Article

References (21)

1. Whitley R.J., Ch#x0027;ien L.T., Dolin R., et al. Adenine arabinoside therapy of herpes zoster in the immunosuppressed: NIAID Collaborative Antiviral Study. N Engl J Med. 1976; 294:1193-1199
2. Whitley R.J., Soong S., Dolin R., et al. Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis: National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study. N Engl J Med. 1977; 297:289-294
3. Saral R., Burns W.H., Laskin O.L., Santos G.W., Lietman P.S. Acyclovir prophylaxis of herpes-simplex-virus infections: a randomized, double-blind, controlled trial in bone-marrow-transplant recipients. N Engl J Med. 1981; 305:63-67
4. Elion G.B., Furman P.A., Fyfe J.A., de Miranda P., Beauchamp L., Schaeffer H.J. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine. Proc Natl Acad Sci USA. 1977; 74:5716-5720
5. Crumpacker C.S., Schnipper L.E., Zaia J.A., Levin M.J. Growth inhibition by acycloguanosine of herpesviruses isolated from human infections. Antimicrob Agents Chemother. 1979; 15:642-645
6. De Clercq E., Descamps J., De Somer P., Barr P.J., Jones A.S., Walker R.T. E-5-(2-bromovinyl)-2′-deoxyuridine: a potent and selective anti-herpes agent. Proc Natl Acad Sci USA. 1979; 76:2947-2951
7. Furman P.A., St Clair M.H., Fyfe J.A., Rideout J.L., Keller P.M., Elion G.B. Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl)guanine and its triphosphate. J Virol. 1979; 32:72-77
8. Allaudeen U.S., Kozarich J.W., Bertino J.R., De Clercq E. On the mechanism of selective inhibition of herpesvirus replication by (E)-5-(2-bromovinyl)-2′-deoxyuridine. Proc Natl Acad Sci USA. 1981; 78:2698-2702
9. Crumpacker C.S., Schnipper L.E., Kowalsky P., Sherman D. Multiple resistance to antiviral drugs in herpes simplex virus is due to physical linkage of resistance mutations on the genome. J Infect Dis. (in press).
10. Knopf K.W., Kaufman E.R., Crumpacker C. Physical mapping of drug resistance mutations defines an active center on the herpes simplex virus DNA polymerase enzyme. J Virol. 1981; 39:746-757
11. Stalder H., Oxman M.N., Hermann K.L. Herpes simplex virus microneutralization: a simplification of the test. J Infect Dis. 1975; 131:423-430
12. Crumpacker C.S., Chartrand P., Subak-Sharpe J.H., Wilkie N.M. Resistance of herpes simplex virus to acycloguanosine — genetic and physical analysis. Virology. 1980; 105:171-184
13. Jamieson A.T., Gentry G.A., Subak-Sharpe J.H. Induction of both thymidine and deoxycytidine kinase activity by herpes viruses. J Gen Virol. 1974; 24:465-480
14. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J Biol Chem. 1951; 193:265-275
15. De Clercq E., Descamps J., Verhelst G., et al. Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus. J Infect Dis. 1980; 141:563-574
16. Schnipper L.E., Crumpacker C.S. Resistance of herpes simplex virus to acycloguanosine: role of viral thymidine kinase and DNA polymerase loci. Proc Natl Acad Sci USA. 1980; 77:2270-2273
17. Coen D., Schaffer P.A. Two distinct loci confer resistance to acycloguanosine in herpes simplex virus type 1. Proc Natl Acad Sci USA. 1980; 77:2265-2269
18. Darby G., Field H.J., Salisbury S.A. Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistance. Nature. 1981; 289:81-83
19. Field H., McMillan A., Darby G. The sensitivity of acyclovir-resistant mutants of herpes simplex virus to other antiviral drugs. J Infect Dis. 1981; 143:281-285
20. Field H.J., Darby G. Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo. Antimicrob Agents Chemother. 1980; 17:209-216
21. Sibrack C.D., Gutman L.T., Wilfert C.M., McLaren C., Barry D. Altered pathogenicity of acyclovir resistant HSV from an immune deficient child. Pediatr Res. 1981; 15:621. abstract.